Introduction
Juvenile X-linked retinoschisis (XLRS) was described as early as 1898 by Haas 1 and several years later, it was identified by Mann and MacRae 2 in 1938 to have an X-linked recessive inheritance. It occurs almost exclusively in males and is characterized by a progressive decrease of central visual acuity in the early years of life and the presence of foveal cystic, spoke wheel-like lesions at the macula, which are apparent on fundus examination. A typical feature of this disease is a selective or predominant reduction of the scotopic b-wave amplitude (negative ERG) upon stimulation of the retina with a white-light single flash. 3 However, Renner et al reported that 40% of XLRS patients did not show a negative ERG. 3 Mutations in the RS1 gene have been described in patients affected with this disease. 4 The gene has six exons encoding for the retinoschisin polypeptide of 224 amino acids, which is synthesised in photoreceptor cell inner segments and provides cell adhesion and proper interaction between cells within the inner nuclear layer, as well as synaptic connections between bipolar cells and photoreceptors. [5] [6] [7] [8] [9] The mutant RS1 gene primarily causes the inner retinal layers to split. Histopathological examinations suggest that the likely primary lesion in X-linked retinoschisis occurs initially in the innermost portion of the Mü ller cells or at the border of the retinal nerve fibre layer. [10] [11] [12] In patients with XLRS, mutations in the RS1 gene lead to the accumulation of retinoschisin within the inner retina 13 and the development of cystic-like spaces primarily in the inner nuclear and outer plexiform layers of the retina as observed by optical coherence tomography (OCT). [14] [15] [16] A recent study by Apushkin et al 17 suggested that reduction of visual acuity does not correspond to the size of cystic areas or retinal thickness of the macula as evaluated by time-domain optical coherence tomography (OCT). Gerth et al, 18 using high-resolution OCT, concluded that there is disturbed foveal photoreceptor cell layer integrity in XLRS patients. Retinal layer abnormalities correlated with age but did not appear to correlate with visual acuity loss or with genotypic variation.
The purpose of the this study was to use high-speed, high-resolution Fourier domain OCT (FD-OCT) to evaluate the presence of any retinal nerve fibre layer (RNFL) defects in patients with XLRS.
Materials and methods

Participants
The study was conducted in the Department of Ophthalmology at the University of Illinois at Chicago. It followed the tenets of the Declaration of Helsinki and was approved by an institutional review board at the University of Illinois. Twenty-four patients (43 eyes) with XLRS were included, and informed consent was obtained from all participants.
The diagnosis of XLRS was based on the history of a decrease in central vision within the first decade of life, selective or predominant reduction of the ERG b-wave in light-and dark-adapted responses, and presence of characteristic fundus cystic lesions in the macula.
Patients with a diagnosis of XLRS who were seen by the authors (MAG and GAF) during their routine clinical follow-up examinations were included in the present study if they were willing to undergo OCT testing. Additional patients previously seen by one of the authors (GAF) were contacted by telephone and asked to participate in the study on the basis of their earlier diagnosis of XLRS.
Exclusion criteria included an inability to maintain steady fixation, past history of glaucoma and/or increased intraocular pressure of X21 mm Hg, pseudophakic and aphakic patients, posterior uveitis, diabetic retinopathy, optic neuropathies, spherical refraction of more than ± 6 dioptres (D) or cylinder refraction of ± 2 D, or any central media opacity sufficient to hinder an OCT examination. No patients with a history of any systemic diseases such as hypertension or diabetes mellitus were included.
Ocular examination
All patients underwent a complete eye examination, including best-corrected visual acuity (BCVA), using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart (The Lighthouse, Long Island City, NY, USA), slitlamp biomicroscopic examination of the anterior segment, and intraocular pressure (IOP) measurement with Goldmann applanation tonometry. A pachymetry measurement (Nidek Inc., Fremont, CA, USA) was made if the IOP pressure was between 18 and 20 mm Hg on two readings or the optic disc showed any degree of pallor. Both eyes were dilated with 2.5% phenylephrine and 1% tropicamide. Fundus examination was performed using both direct and indirect ophthalmoscopy as well as biomicroscopy with a noncontact 78 D lens, and any optic disc pallor was recorded.
Optical coherence tomography (OCT) techniques
OCT was performed using Optovue technology (RTvue version 3.5; Optovue Inc., Fremont, CA, USA). The NMH 4 protocol was used for scan acquisition, which consisted of 12 radial line scans, 3.4 mm in length, and six concentric rings (2.5-4.0 mm diameter), all centred on the optic disc. Internal fixation was used for all patients. The total time for a single scan acquisition was 0.39 s. Scans were accepted only if they had a signal strength index greater than 35 and were free of artefacts.
RNFL thickness was measured automatically by the existing software at a diameter of 3.45 mm around the centre of the optic disc. The total number of A-scans at that circumference was 9510. RNFL thickness was measured in the superior (46-1351), nasal (316-451 for the right and 136-2251 for the left), inferior (226-3151), and temporal (136-2251 for the right and 316-451 for the left) quadrants. OCT software automatically measured four smaller segments within each quadrant (Figures 1 and 2 ). Data thus obtained were compared with the normative database provided with the software, taking the patient age and size of the optic disc into account.
RNFL thickness was measured at least three times for each eye and data were used only if the scans were reproducible, within either a normal or an abnormal range, in at least two-third of the scan acquisitions. Also, eyes with scans inconsistent on the first set of three OCT RNFL scans were rescanned with another set of three scans. We then used the criteria that two-third of these scans should be consistent as either normal or abnormal in order to be included in the analysis. In 29 eyes (67.4%) only one set of scans was required, while in 14 eyes (32.6%) two sets of scans were required.
One hundred forty-three OCT scans were obtained on 43 eyes (one eye each was tested in five patients and both eyes were tested in 19 patients). Inner and outer automated machine-drawn contour lines which mark the boundary of the nerve fibre layer were examined in each scan and scans with boundary line misplacements leading to the distortion of the contour lines were excluded. The contour of the optic nerve head was manually traced using a fundus image generated by the OCT.
For detecting changes within the macula in the XLRS patients, we also scanned the macula using both the MM5 and the Radial Lines protocols. The radial scan consisted of twelve 6 mm radial scans at 151 intervals passing through the centre of the fovea. All 12 scans were acquired simultaneously and the total time taken for their acquisition was 0.27 s. Each radial line consisted of 1024 A-scans.
The MM5 scan protocol consisted of 11 horizontal and 11 vertical line scans with 5 mm scan length and 0.5 mm interval and 6 horizontal and 6 vertical line scans with 3 mm scan length and 0.5 mm interval, all centred at the fovea, with a total acquisition time of 0.78 s.
Data analyses
Segmental analysis with reference to colour-coded normative data The RNFL was considered abnormally thin for an individual if its value was less than the 5th percentile of the age-and optic disc size-adjusted normal values and thick if it was more than the 95th percentile. Abnormal thinning or thickness in at least two of the four segments within a quadrant, if reproducible, was considered significant for that quadrant.
Quantitative analysis for individual quadrants
We measured the thickness of the RNFL ±2 SD quantitatively in each of the four quadrants and compared these values with normative data provided to us by the company that were not corrected for age and optic disc size and which were retrieved from 268 eyes of 134 normative control participants (mean age of 44.1 ± 15.5 years).
Statistical analysis
Differences between the mean peripapillary RNFL thickness in our study population and that from the normative data were analysed by the two-tailed Student t-test. A probability value of less than 0.05 was considered statistically significant. As most of the participants had a symmetrically equivalent RNFL thickness between eyes, the mean RNFL thickness of each patient whose scans were included for both eyes was calculated as a single number, so that an analysis was performed on a by-person basis. Differences were studied for the thickness in overall circumference, hemispheres (superior and inferior), and quadrants (superior, nasal, inferior, and temporal). The association between the presence of RNFL thinning (by segmental analysis) and age was also analysed using Fisher's Exact test in the by-eye analysis.
Results
Twenty-four patients with the diagnosis of juvenile XLRS were included in our study. We included 43 eyes: 23 right eyes (53.5%) and 20 left eyes (46.5%). In 5 patients (20.8%), only one eye was included because of the presence of a traumatic cataract, rotatory nystagmus, old retinal detachment, or poor patient fixation, which made the acquisition of a reliable RNFL scan difficult.
The average age of the 24 patients in the study was 28.8 ± 14.7 years, with a range from 10 to 54 years. There were 22 Caucasian (91.7%) and 2 Hispanic (8.3%) patients enroled in the study. In 14 patients (58.3%), the abnormal disease-causing gene was identified earlier (Table 1) The range of IOP for all patients was from 8 to 17 mm Hg in the right eyes (mean 13.0 mm Hg and SD 2.4), while the range of IOP in left eyes was from 10 to 17 mm Hg (mean 12.8 mm Hg and SD 2.2). None of the patients had a glaucomatous appearance to the optic disc. Three patients (14.3%) had a mild temporal disc pallor clinically in both eyes. Two out of the three patients showed thinning in the RNFL thickness in the temporal quadrants, while the other patient showed thinning of the RNFL in the superior, nasal, and inferior quadrants, with normal RNFL thickness in the temporal quadrant.
Among our 24 patients with XLRS, 15 patients (62.5%) showed a thinning of the RNFL in one or more quadrants in at least one eye and 9 patients (37.5%) in both eyes. Thinning of the RNFL in one quadrant was seen in 12 eyes (27.9%) of 10 patients (41.7%), and thinning in two or more quadrants was seen in 12 eyes (27.9%) of 8 patients (33.3%). It should be noted that RNFL thinning was present in 7 (87.5%) of 8 patients who were older than 35 years of age. All of the seven patients had thinning of RNFL in at least one quadrant in all studied eyes (five patients whose both eyes were included, and two patients whose only one eye was studied). For those who were less than 35 years old, thinning of RNFL in at least one quadrant was observed in 9 (56.3%) of 16 patients. In those nine patients, seven patients were studied bilaterally, and four of the seven patients showed thinning in only one eye. There was a statistically significant difference for the presence of RNFL thinning in at least one quadrant in the older (X35 years old) compared to the younger age group (o35 years old) (P ¼ 0.0028). The significant difference was still demonstrated at the cut-off age of 30 years (P ¼ 0.0477).
Regarding the distribution of abnormal thinning of the RNFL among the four quadrants, thinning in the inferior quadrant was most commonly seen in 18 eyes (41.9%) of 12 patients (50%), followed by the temporal quadrant in 12 eyes (27.9%) of 8 patients (33.3%), nasal quadrant in 5 eyes (11.6%) of 4 patients (16.7%), and the superior quadrant in 5 eyes (11.6%) of 4 patients (16.7%) (Figures 1  and 2) .
We also found the overall average RNFL thickness at a diameter of 3.45 mm in our study population to be 100.95 mm with a SD of ± 16.02, compared with normative data, where the average RNFL thickness was 106.72 mm with a SD of ± 11.34. The patients with retinoschisis had a statistically significant difference of mean RNFL thickness compared with the normative data (P ¼ 0.034).
By assessing the RNFL thickness quantatively in each quadrant, compared with the values of the mean RNFL thickness ± 2SD provided by the manufacturer, using the criteria of calculating the average RNFL thickness ± 2SD for each quadrant, we found that 14 eyes (32.6%) had statistically significant thinning of the RNFL in the inferior quadrant, while only 1 eye (2.3%) had a thicker than normal RNFL in the inferior quadrant. We additionally found that 5 eyes (11.6%) had thinning of the RNFL in the temporal quadrant whereas 4 eyes (9.3%) had a thicker than normal RNFL in the temporal quadrant. We were unable to find any RNFL thickness defects in either the superior or the nasal quadrants by this quantitative method of analysis that did not account for age or optic disc size.
Further, we calculated the average RNFL thickness of all patients from all quadrants and compared these values with the normative values provided by the manufacturer uncorrected for age or optic disc size. As shown in Table 2 , statistically significant differences in mean RNFL thickness were seen only in the inferior and temporal quadrants. There were no statistically significant differences in mean RNFL thickness in any quadrants, when comparing between the right and left eyes (P-values ranged between 0.516 and 0.998).
The overall average for the RNFL thickness in the superior hemisphere was 105.69 mm (SD ± 15.82), while in the control group the average thickness was 106.59 mm (SD ± 12.68). In the inferior hemisphere the overall average was 95.43 mm (SD ±17.48), while in the control group it was 106.84 mm (SD ±11.53). There was no statistically significant difference shown in the superior hemisphere (P ¼ 0.7586), but a statistical difference was shown in the inferior hemisphere (Po0.0001).
All patients included in the study were also examined by FD-OCT for the presence of cystic changes within the macula using the MM5 and the Radial Lines examination protocols. Macular cysts were observed in 29 eyes (67.4%) from 18 patients (75.0%).
Discussion
In our cohort of 24 patients with XLRS, 15 patients (62.5%) showed a thinning of the RNFL in one or more quadrants in at least one eye by the criteria referenced to colour-coded normative data for segments within each quadrant. Abnormal thinning was more commonly found in the inferior and temporal quadrants. The nasal and the superior quadrants were equally affected and both showed thinning in fewer eyes than were seen in the inferior and temporal quadrants. A direct quantitative comparison between quadrants using data computed directly for each quadrant also confirmed a significant reduction of mean RNFL thickness in the inferior and temporal quadrants in our patients compared with the normative data.
The segmental analysis for determining quadrant defects was based on normative data corrected for age and disc size provided by the manufacturer. Owing to a proprietary limitation, the normal values from specific age groups were unavailable for our directly computed quantitative analysis of each quadrant. The normative data used herein were retrieved from visually normal subjects at a wide range of age. Therefore, the mean age of our study subjects was lower than that of the normative data. However, this limitation would not likely have affected our conclusions as we would more likely have anticipated a thicker RNFL in the younger patients had their RNFL not been affected by their disease. 19 It is possible that we may have found even greater statistically significant results in our analysis if we could have used data from similar-aged controls in this portion of our directly computed quadrant analysis.
The finding of changes in the RNFL of our XLRS patients might have been anticipated in reference to a report by Yanoff et al, 10 which stated that the primary pathology in XLRS was located in the inner retinal layers. Other earlier studies based on histopathological analysis have suggested that the likely primary lesion in XLRS occurs initially in the innermost portion of Mü ller cells or at the border of the RNFL. [10] [11] [12] Also, our finding of RNFL thinning is in agreement with the earlier studies by Manschot 11 and Condon et al, 12 which described optic nerve atrophy in XLRS patients. Using a time-domain scanning procedure of the macula, Apushkin et al 17 did not observe any thinning of the papillo-macular bundle RNFL thickness on OCT imaging in patients with juvenile XLRS and no clinical findings of optic disc pallor.
One of the potential limitations of this study was that the drawing of the margins of the optic discs was done manually for all patients; hence, the size of the optic disc might have been subjectively influenced by the operator. Further, another parameter that might have influenced the RNFL thickness measured by OCT was the axial length of the eye, 20-22 because we did not correct for this factor in the directly computed quadrantquantitative analysis portion of our study when using values for various quadrants compared with the normative data provided by the manufacturer, which also did not correct for axial length. However, we included only patients with a lower degree of refractive error in whom a normal or close-to-normal axial length might be assumed.
Our study showed that older XLRS patients were more likely to show RNFL thinning, which suggests that the younger patients might have a higher potential to benefit from treatment. This has potential significance for future treatment trials in patients with XLRS in which patient selection might be influenced by the degree of thinning in their RNFL. However, this hypothesis needs to be confirmed in future treatment trials. Nonetheless, highspeed, high-resolution tools such as FD-OCT may be useful to measure RNFL thickness during patient selection in future therapeutic trials on patients with XLRS. Only one answer is correct for each question.
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1.
Which of the following is characteristic of X-linked retinoschisis (XLRS)? 
